First results of the HEVACC Study using Askimed's data collection + survey feature are out. Preliminary results show that a heterologous vaccination leads to a stronger immune response #ecrf#survey#clinicaltrial
Great to see the progress in the TirolGESUND study 🚀 Congrats to Chiara, Martin and the complete team. We are really happy to support this study with our platform. If you have a study a mind 🧠, contact us or write @SinaTschiderer directly. #surveys#edc